FROG.NASDAQJfrog LTD

Form 4: JFrog's Chief Technology Officer, Yoav Landman, Sells Shares Under 10b5-1 Trading Plan

Sentiment:

SEC Form 4 Filing


Yoav Landman, Chief Technology Officer of JFrog Ltd, executed sales of ordinary shares on August 9, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • Yoav Landman, the Chief Technology Officer of JFrog Ltd, sold ordinary shares on August 9, 2024.
  • The sales were executed under a Rule 10b5-1 trading plan adopted on August 11, 2023.
  • A total of 2,162 shares were sold at a weighted average price of $24.82, with prices ranging from $24.38 to $25.31.
  • An additional 12,838 shares were sold at a weighted average price of $25.82, with prices ranging from $25.41 to $26.15.
  • Following these transactions, Landman beneficially owns 6,642,242 ordinary shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to insider trading. It doesn't inherently convey positive or negative sentiment, as it simply reports transactions. The sentiment is neutral.

Industry Context

Sales by company insiders are a common occurrence, often executed under pre-arranged trading plans like Rule 10b5-1 to avoid accusations of insider trading. The market typically analyzes these sales in the context of the company's performance and future prospects.

Stakeholder Impact

  • Shareholders may react to insider sales, although sales under a 10b5-1 plan are generally viewed as less impactful than discretionary sales.

Key Dates

DateDescription
2023/08/11Date of adoption of Rule 10b5-1 trading plan
2024/08/09Date of share sale transactions
2024/08/13Date of Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.